COVID-19 update: Genoskin to maintain US production activity during pandemic.
Genoskin COVID-19 research preferred access program On Friday, March 13th 2020,
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Genoskin in the News: article on Benzinga
13 August 2020
Genoskin’s CEO invited to talk at Empowered Patient Podcast
28 July 2020
Brand new sustainable and user-friendly packaging!
6 July 2020
Genoskin to attend BIO Digital 2020 next week
4 June 2020
Genoskin featured in a Business Insider article
16 May 2020